Acne vulgaris
First line
First-line systemic antibiotic for moderate-to-severe acne per AAD 2024 guidelines. Dose is 100 mg once or twice daily for 3 months. Sub-antimicrobial dose of 40 mg modified-release (not registered in Russia) reduces inflammation without antibiotic pressure. Always combine with a topical retinoid and/or benzoyl peroxide to prevent resistance.